Lisa Caldwell is responsible for working with teams across Johnson & Johnson on the potential launch of our investigational COVID-19 vaccine candidate, if proven to be effective with a good safety profile. Before taking this role, Lisa led the Janssen Global Commercial Strategy for Bacterial Vaccines, partnering closely with the full cross-functional team working in this space.
Prior to joining the Johnson & Johnson Family of Companies, Lisa was the Global Marketing Director for a shingles vaccine at GSK. In this capacity, she and her team helped shape the launch, go-to-market strategy, stakeholder education and communications for North America and Europe, while planning for expansion in China and Japan. Prior to this role, Lisa led the U.S. Vaccines Consumer Strategy team at GSK. She played a key role in embedding a new capability in the business unit, while delivering strong business results for the adult and adolescent portfolio.
Before joining GSK, Lisa spent 15 years at Merck in roles of increasing responsibility across several primary care and specialty brands at various stages of the product life cycle.
Lisa graduated from Howard University with a Bachelor of Science in Microbiology and received a Master of Business Administration from Pennsylvania State University.